At the time, the CGM devices used in this study were all early generation; they were larger than current devices, and they required fingerstick calibrations in addition to fingerstick glucose checks for any treatment decisions, including insulin dosing or treating hypoglycemia. The gene discussed is INS; the disease is Hypoglycemia.